AF
Allworth Financial Portfolio holdings
AUM
$20.8B
1-Year Return
12.38%
This Quarter Return
+7.71%
1 Year Return
+12.38%
3 Year Return
+38.45%
5 Year Return
+53.41%
10 Year Return
+94.66%
AUM
$20.8B
AUM Growth
+$3.11B
(+18%)
Cap. Flow
+$1.67B
Cap. Flow
% of AUM
8.03%
Top 10 Holdings %
Top 10 Hldgs %
49.36%
Holding
4,689
New
639
Increased
2,505
Reduced
743
Closed
112
Top Buys
| 1 |
Apple
AAPL
|
+$116M |
| 2 |
NVIDIA
NVDA
|
+$103M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$47.5M |
| 4 |
Microsoft
MSFT
|
+$35M |
| 5 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$34.7M |
Top Sells
Sector Composition
| 1 | Technology | 6.68% |
| 2 | Financials | 2.92% |
| 3 | Healthcare | 1.88% |
| 4 | Industrials | 1.82% |
| 5 | Consumer Discretionary | 1.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACV
3926
Virtus Diversified Income & Convertible Fund
ACV
$244M
| $1.1K | ﹤0.01% |
+48
| New | +$1.1K |
|
3927
Replimune Group
REPL
$471M
| $1.1K | ﹤0.01% |
118
-170
| -59% | -$1.58K |
|
3928
Xenon Pharmaceuticals
XENE
$2.94B
| $1.1K | ﹤0.01% |
35
+23
| +192% | +$720 |
|
3929
Carter Bankshares
CARE
$448M
| $1.09K | ﹤0.01% |
+63
| New | +$1.09K |
|
3930
Alamo Group
ALG
$2.56B
| $1.09K | ﹤0.01% |
5
+2
| +67% | +$437 |
|
3931
IMAX
IMAX
$1.67B
| $1.09K | ﹤0.01% |
39
| – | – |
|
3932
Weis Markets
WMK
$1.76B
| $1.09K | ﹤0.01% |
15
+5
| +50% | +$363 |
|
3933
Core Scientific, Inc. Tranche 1 Warrants
CORZW
$818M
| $1.08K | ﹤0.01% |
100
| – | – |
|
3934
Cytek Biosciences
CTKB
$522M
| $1.08K | ﹤0.01% |
+317
| New | +$1.08K |
|
3935
Colony Bankcorp
CBAN
$300M
| $1.07K | ﹤0.01% |
65
-69
| -51% | -$1.14K |
|
3936
89bio
ETNB
$1.27B
| $1.07K | ﹤0.01% |
+109
| New | +$1.07K |
|
3937
Northeast Community Bancorp
NECB
$277M
| $1.07K | ﹤0.01% |
+46
| New | +$1.07K |
|
3938
Gores Guggenheim
PSNY
$2.18B
| $1.07K | ﹤0.01% |
1,000
| – | – |
|
3939
Amalgamated Financial
AMAL
$871M
| $1.07K | ﹤0.01% |
34
-31
| -48% | -$973 |
|
3940
B. Riley Financial
RILY
$156M
| $1.05K | ﹤0.01% |
+355
| New | +$1.05K |
|
3941
Tenaris
TS
$18.2B
| $1.05K | ﹤0.01% |
28
-2
| -7% | -$75 |
|
3942
Xometry
XMTR
$2.63B
| $1.05K | ﹤0.01% |
31
+7
| +29% | +$237 |
|
3943
N-able
NABL
$1.56B
| $1.04K | ﹤0.01% |
128
-180
| -58% | -$1.46K |
|
|
TEI
3944
Templeton Emerging Markets Income Fund
TEI
$295M
| $1.03K | ﹤0.01% |
172
+4
| +2% | +$24 |
|
3945
Transcat
TRNS
$743M
| $1.03K | ﹤0.01% |
12
| – | – |
|
3946
Arcturus Therapeutics
ARCT
$484M
| $1.03K | ﹤0.01% |
79
-21
| -21% | -$273 |
|
3947
Payoneer
PAYO
$2.44B
| $1.03K | ﹤0.01% |
150
-111
| -43% | -$761 |
|
|
AVDL
3948
Avadel Pharmaceuticals
AVDL
$1.49B
| $1.03K | ﹤0.01% |
116
+87
| +300% | +$770 |
|
3949
TriNet
TNET
$3.38B
| $1.03K | ﹤0.01% |
14
+4
| +40% | +$293 |
|
3950
Dole
DOLE
$1.29B
| $1.01K | ﹤0.01% |
+72
| New | +$1.01K |
|